Premium
Structural Determinants of the Alzheimer's Amyloid β‐Peptide
Author(s) -
Soto Claudio,
Brañes María Cecilia,
Alvarez Jaime,
Inestrosa Nibaldo C.
Publication year - 1994
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1046/j.1471-4159.1994.63041191.x
Subject(s) - senile plaques , peptide , amyloid (mycology) , p3 peptide , chemistry , biophysics , sequence (biology) , protein primary structure , peptide sequence , amyloid precursor protein , extracellular , alzheimer's disease , biochemistry of alzheimer's disease , membrane , biochemistry , biology , pathology , disease , medicine , inorganic chemistry , gene
The hallmark event of Alzheimer's disease (AD) is the deposition of amyloid as insoluble fiber masses in extracellular neuritic plaques and around the walls of cerebral blood vessels. The main component of amyloid is a hydrophobic peptide, named amyloid β‐peptide (βA4), which results from the processing of a much longer membrane amyloid precursor protein (APP). This review focuses on the structural features of βA4 and the factors that determine βA4 insolubilization. Theoretical and experimental studies of the primary structure of βA4 have shown that it is composed of a completely hydrophobic C‐terminal domain, which adopts β‐strand structure, and an N‐terminal region, whose sequence permits different secondary structures. In fact, this region can exist as an α‐helical or β‐strand conformation depending on the environmental condition (pH and hydrophobicity surrounding the molecule). The effects of pH and hydrophobicity on βA4 structure may elucidate the mechanisms determining its aggregation and amyloid deposition in AD.